Anbio Biotechnology Class A Ordinary Shares
General ticker "NNNN" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.1B (TTM average)
Anbio Biotechnology Class A Ordinary Shares does not follow the US Stock Market performance with the rate: -33.6%.
Estimated limits based on current volatility of 4.4%: low 3.54$, high 3.86$
Factors to consider:
- Total employees count: 27 (0.0%) as of 2025
Short-term NNNN quotes
Long-term NNNN plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6.71MM | $8.19MM | $8.65MM |
| Operating Expenses | $4.75MM | $6.19MM | $2.88MM |
| Operating Income | $1.96MM | $2.00MM | $5.77MM |
| Non-Operating Income | $0.29MM | $0.38MM | $0.64MM |
| R&D Expense | $0.13MM | $0.45MM | $0.20MM |
| Income(Loss) | $2.25MM | $2.37MM | $6.40MM |
| Net Income(Loss)* | $2.25MM | $2.37MM | $6.40MM |
| Stockholders Equity | $14.82MM | $17.19MM | $30.16MM |
| Assets | $15.81MM | $18.92MM | $30.24MM |
| Operating Cash Flow | $0.90MM | $2.08MM | $-6.74MM |
| Investing Cash Flow | $1.73MM | $0.34MM | $-4.20MM |
| Financing Cash Flow | $-0.04MM | $-0.34MM | $6.95MM |
| Earnings Per Share** | $0.02 | $0.06 | $0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.